Adjuvant Global Health Technology Fund, L.P.

Insider Reports History

Entity
Company
Location
C/O Adjuvant Capital, L.P., 501 Fifth Avenue, Suite 1404, New York, NY
Signature
Adjuvant Global Health Technology Fund, L.P., By: Adjuvant Capital GP, L.P., its sole general partner, By: Adjuvant Capital Management, L.L.C., its sole general partner, By: Kabeer Aziz, Secretary, /s/ Kabeer Aziz
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Adjuvant Global Health Technology Fund, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AN2 Therapeutics, Inc. 10%+ Owner Common Stock 2M $38.2M $19.11 Jan 16, 2024 Direct
AN2 Therapeutics, Inc. 10%+ Owner Common Stock 378K $7.22M $19.11 Jan 16, 2024 By Adjuvant Global Health Technology Fund DE, L.P.

Insider Reports Filed by Adjuvant Global Health Technology Fund, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ANTX AN2 Therapeutics, Inc. Jan 16, 2024 2 -$1.97M 4 Jan 18, 2024 10%+ Owner
ANTX AN2 Therapeutics, Inc. Nov 14, 2023 2 -$29.2K 4 Nov 16, 2023 10%+ Owner
ANTX AN2 Therapeutics, Inc. Sep 29, 2023 4 -$1.7M 4 Oct 3, 2023 10%+ Owner
ANTX AN2 Therapeutics, Inc. Sep 27, 2023 4 -$151K 4 Sep 29, 2023 10%+ Owner
ANTX AN2 Therapeutics, Inc. Aug 23, 2023 2 -$6.4K 4 Sep 15, 2023 10%+ Owner
ANTX AN2 Therapeutics, Inc. Aug 23, 2023 4 -$114K 4 Sep 8, 2023 10%+ Owner
ANTX AN2 Therapeutics, Inc. Aug 23, 2023 2 -$6.4K 4 Aug 25, 2023 10%+ Owner
ANTX AN2 Therapeutics, Inc. Jun 6, 2022 2 $0 4 Jun 24, 2022 10%+ Owner
ANTX AN2 Therapeutics, Inc. Mar 29, 2022 9 $2.5M 4/A Jun 24, 2022 10%+ Owner
ANTX AN2 Therapeutics, Inc. Mar 24, 2022 0 $0 3/A Jun 24, 2022 10%+ Owner